The role of 5-HT1A receptors in the behavioral responses associated with innate fear

被引:8
|
作者
Shields, Jessica [1 ]
King, Jean A. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Psychiat, Ctr Comparat NeuroImaging, Worcester, MA 01655 USA
关键词
serotonin; 5-HT1A receptor; innate fear; corticosterone;
D O I
10.1037/0735-7044.122.3.611
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Fear is a response induced by threatening stimuli and represents an important adaptive system. The serotonin (5-HT) system has been shown to be involved in the modulation of fear responses and anxiety disorders. In preclinical studies, it has been demonstrated that R (+)-8-hydroxy-dipropylaminotetralin (8-OHDPAT), a 5-HT1A agonist, has anxiolytic properties. However, 8-OHDPATs potential role in unconditioned fear has yet to be elucidated. The current study was designed to investigate the effects of 8-OHDPAT on behavioral and HPA axis function in response to an innate fear-inducing stimulus. Pretreatment with 8-OHDPAT resulted in a significant decrease in freezing grooming, and climbing and caused a significant increase in approach after exposure to an extract from fox feces, 2,5-dihyrdo-2,4,5-trimethylthiazoline (TMT), an unconditioned fear-inducing stimulus. Furthermore, 8-OHDPAT pretreatment also resulted in a significant decrease in blood corticosterone levels, a marker of HPA activation. Taken together, these results suggest an additional anxyolitic-like effect of 8-OHDPAT in innate fear paradigms.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 50 条
  • [41] Serotonin and inhibitory response control: Focusing on the role of 5-HT1A receptors
    Pattij, Tommy
    Schoffelmeer, Anton N. M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 753 : 140 - 145
  • [42] Involvement of presynaptic 5-HT1A and benzodiazepine receptors in the anticonflict activity of 5-HT1A receptor antagonists
    Wesolowska, A
    Paluchowska, M
    Chojnacka-Wójcik, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 471 (01) : 27 - 34
  • [43] The role of 5-HT1A receptors in emotional memory: implications for anxiety and depression
    Ogren, S. O.
    Eriksson, T. M.
    Kehr, J.
    Svenningsson, P.
    Stiedl, O.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S115 - S116
  • [44] Role of 5-HT1A receptors in fluoxetine-induced lordosis inhibition
    Guptarak, Jutatip
    Sarkar, Jhimly
    Hiegel, Cindy
    Uphouse, Lynda
    HORMONES AND BEHAVIOR, 2010, 58 (02) : 290 - 296
  • [45] Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat
    Lüttgen, M
    Elvander, E
    Madjd, N
    Ögren, SO
    NEUROPHARMACOLOGY, 2005, 48 (06) : 830 - 852
  • [46] Role of 5-HT1A/5-HT2A receptors interaction in the severity of depression and antidepressant response
    Quesseveur, G.
    Petit, A. C.
    Gressier, F.
    Colle, R.
    David, D. J.
    Gardier, A. M.
    Verstuyft, C.
    Sanchez, C.
    Corruble, E.
    Guiard, B. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S131 - S131
  • [47] Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats
    Popova, NK
    Naumenko, VS
    Plyusnina, IZ
    Kulikov, AV
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 80 (02) : 286 - 292
  • [48] Methysergide delays the decompensatory responses to severe hemorrhage by activating 5-HT1A receptors
    Scrogin, KE
    Johnson, AK
    Brooks, VL
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 279 (05) : R1776 - R1786
  • [49] A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: Reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors
    Li, Q
    Muma, NA
    Battaglia, G
    VanDeKar, LD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (03): : 1581 - 1590
  • [50] Arylpiperazine derivatives acting at 5-HT1A receptors
    López-Rodríguez, ML
    Ayala, D
    Benhamù, B
    Morcillo, MJ
    Viso, A
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (04) : 443 - 469